Zobrazeno 1 - 10
of 889
pro vyhledávání: '"Mudie D"'
Autor:
Pepin X; Regulatory Affairs, Simulations Plus Inc., 42505 10th Street West, Lancaster, California 93534-7059, United States., Arora S; Janssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, Belgium., Borges L; ANVISA, SIA Trecho 5́, Guara, Brasília, Federal District 71205-050, Brazil., Cano-Vega M; Drug Product Technologies, Amgen Inc., Thousand Oaks, California 91320-1799, United States., Carducci T; Analytical Commercialization Technology, Merck & Co., Inc., 126 E. Lincoln Ave., Rahway, New Jersey 07065, United States., Chatterjee P; Office of Pharmaceutical Quality (OPQ), Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA), Silver Spring, Maryland 20903-1058, United States., Chen G; Takeda Development Center Americas Inc., 300 Shire Way, Lexington, Massachusetts 02421, United States., Cristofoletti R; College of Pharmacy, University of Florida, 6550 Sanger Rd., Orlando, Florida 32827, United States., Dallmann A; Bayer HealthCare SAS, 59000 Lille, France, on behalf of Bayer AG, Pharmacometrics/Modeling and Simulation, Systems Pharmacology & Medicine, PBPK, Leverkusen, Germany., Delvadia P; Office of Translational Science, Office of Clinical Pharmacology (OCP), Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA), Silver Spring, Maryland 20903-1058, United States., Dressman J; Fraunhofer Institute of Translational Medicine and Pharmacology, Frankfurt am Main 60596, Germany., Fotaki N; University of Bath, Claverton Down, Bath BA2 7AY, United Kingdom., Gray E; Office of Pharmaceutical Quality (OPQ), Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA), Silver Spring, Maryland 20903-1058, United States., Heimbach T; Pharmaceutical Sciences and Clinical Supply, Merck & Co., Inc., Rahway, New Jersey 07065, United States., Holte Ø; Norwegian Medical Products Agency, Oslo 0213, Norway., Kijima S; Office of New Drug V, Pharmaceuticals and Medical Devices Agency (PMDA), Tokyo 100-0013, Japan., Kotzagiorgis E; European Medicines Agency (EMA), Domenico Scarlattilaan 6, Amsterdam 1083 HS, The Netherlands., Lennernäs H; Translational Drug Discovery and Development, Department of Pharmaceutical Bioscience, Uppsala University, Uppsala 751 05, Sweden., Lindahl A; Swedish Medical Products Agency, Uppsala 752 37, Sweden., Loebenberg R; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmontonton T6G 2E1, Canada., Mackie C; Janssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, Belgium., Malamatari M; Medicines & Healthcare Products Regulatory Agency, 10 S Colonnade, London SW1W 9SZ, United Kingdom., McAllister M; Global Biopharmaceutics, Drug Product Design, Pfizer, Sandwich CT13 9NJ, United Kingdom., Mitra A; Clinical Pharmacology, Kura Oncology Inc., Boston, Massachusetts 02210, United States., Moody R; Office of Pharmaceutical Quality (OPQ), Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA), Silver Spring, Maryland 20903-1058, United States., Mudie D; Global Research and Development, Small Molecules, Lonza, 63045 NE Corporate Pl., Bend, Oregon 97701, United States., Musuamba Tshinanu F; Belgian Federal Agency for Medicines and Health Products, Galileelaan 5/03, Brussel 1210, Belgium., Polli JE; School of Pharmacy, University of Maryland, Baltimore, Maryland 21201, United States., Rege B; Office of Pharmaceutical Quality (OPQ), Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA), Silver Spring, Maryland 20903-1058, United States., Ren X; PK Sciences/Translational Medicine, BioMedical Research, Novartis, One Health Plaza, East Hanover, New Jersey 07936, United States., Rullo G; Regulatory CMC, AstraZeneca, 1 Medimmune Way, Gaithersburg, Maryland 20878, United States., Scherholz M; Pharmaceutical Development, Bristol Myers Squibb, Route 206 & Province Line Road, Princeton, New Jersey 08543, United States., Song I; Takeda Development Center Americas Inc., 300 Shire Way, Lexington, Massachusetts 02421, United States., Stillhart C; Pharmaceutical R&D, F. Hoffmann-La Roche Ltd., Basel 4070, Switzerland., Suarez-Sharp S; Regulatory Affairs, Simulations Plus Inc., 42505 10th Street West, Lancaster, California 93534-7059, United States., Tannergren C; Biopharmaceutics Science, New Modalities & Parenteral Product Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Gothenburg 431 50, Sweden., Tsakalozou E; Division of Quantitative Methods and Modeling, Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland 20903-1058, United States., Veerasingham S; Pharmaceutical Drugs Directorate (PDD), Health Canada, 1600 Scott St., Ottawa K1A 0K9, Canada., Wagner C; Global Drug Product Development, Global CMC Development, the Healthcare Business of Merck KGaA, Darmstadt D-64293, Germany., Seo P; Office of Translational Science, Office of Clinical Pharmacology (OCP), Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA), Silver Spring, Maryland 20903-1058, United States.
Publikováno v:
Molecular pharmaceutics [Mol Pharm] 2024 Aug 05; Vol. 21 (8), pp. 3697-3731. Date of Electronic Publication: 2024 Jun 30.
Autor:
Pluntze A; Global Research and Development, Small Molecules, Lonza, 64550 Research Road, Bend, OR 97703, USA., Beecher S; Global Research and Development, Small Molecules, Lonza, 64550 Research Road, Bend, OR 97703, USA., Anderson M; Global Research and Development, Small Molecules, Lonza, 64550 Research Road, Bend, OR 97703, USA., Wright D; Global Research and Development, Small Molecules, Lonza, 64550 Research Road, Bend, OR 97703, USA., Mudie D; Global Research and Development, Small Molecules, Lonza, 64550 Research Road, Bend, OR 97703, USA.
Publikováno v:
Pharmaceutics [Pharmaceutics] 2024 Jan 05; Vol. 16 (1). Date of Electronic Publication: 2024 Jan 05.
Autor:
Edueng K; Department of Pharmacy, Uppsala University, Husargatan 3, 75 123 Uppsala, Sweden., Kabedev A; Department of Pharmacy, Uppsala University, Husargatan 3, 75 123 Uppsala, Sweden., Ekdahl A; Cockrell School of Engineering, The University of Texas at Austin, Austin, TX 78712, USA., Mahlin D; Department of Pharmacy, Uppsala University, Husargatan 3, 75 123 Uppsala, Sweden; AstraZeneca Operations, Forskargatan 18, 151 85 Södertälje, Sweden., Baumann J; Global Research and Development, Lonza, Bend, OR 97703, USA., Mudie D; Global Research and Development, Lonza, Bend, OR 97703, USA., Bergström CAS; Department of Pharmacy, Uppsala University, Husargatan 3, 75 123 Uppsala, Sweden; The Swedish Drug Delivery Center, Department of Pharmacy, Uppsala University, Husargatan 3, 75123 Uppsala, Sweden. Electronic address: christel.bergstrom@farmaci.uu.se.
Publikováno v:
International journal of pharmaceutics [Int J Pharm] 2022 Feb 05; Vol. 613, pp. 121360. Date of Electronic Publication: 2021 Dec 09.
Autor:
FitzGerald, Laura I.1 (AUTHOR), Hahn, Erin E.2 (AUTHOR), Wallace, Mark3 (AUTHOR), Stephenson, Sarah A.4 (AUTHOR), Berry, Oliver F.5 (AUTHOR) Oliver.Berry@csiro.au, Doherty, Cara M.1 (AUTHOR) Cara.Doherty@csiro.au
Publikováno v:
Small Science. Oct2024, p1. 12p. 7 Illustrations.
Autor:
Lambert KG; Division of Emergency Medicine, Department of Surgery and Perioperative Care, Dell Medical School at the University of Texas, Austin, TX, USA; Emergency Medicine Associates of Cayuga, Ithaca, NY, USA., Aufricht WR; Division of Emergency Medicine, Department of Surgery and Perioperative Care, Dell Medical School at the University of Texas, Austin, TX, USA., Mudie D; Division of Emergency Medicine, Department of Surgery and Perioperative Care, Dell Medical School at the University of Texas, Austin, TX, USA., Brown LH; Division of Emergency Medicine, Department of Surgery and Perioperative Care, Dell Medical School at the University of Texas, Austin, TX, USA. Electronic address: lhbrown@ascencion.org.
Publikováno v:
The American journal of emergency medicine [Am J Emerg Med] 2020 Dec; Vol. 38 (12), pp. 2740-2741. Date of Electronic Publication: 2020 Apr 22.
Autor:
Bermejo M; Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, 428 Church Street, Ann Arbor, MI 48109-1065, USA.; Department of Engineering, Pharmacy Section, Miguel Hernandez University, San Juan de Alicante, 03550 Alicante, Spain., Hens B; Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, 428 Church Street, Ann Arbor, MI 48109-1065, USA.; Department of Pharmaceutical & Pharmacological Sciences, KU Leuven, Herestraat 49, 3000 Leuven, Belgium., Dickens J; Department of Statistics, University of Michigan, Ann Arbor, MI 48109, USA., Mudie D; Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, 428 Church Street, Ann Arbor, MI 48109-1065, USA.; Global Research and Development, Lonza, Bend, OR 97703, USA., Paixão P; Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, 428 Church Street, Ann Arbor, MI 48109-1065, USA.; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Avenida Professor Gama Pinto, 1649-003 Lisboa, Portugal., Tsume Y; Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, 428 Church Street, Ann Arbor, MI 48109-1065, USA.; Merck & Co., Inc., 126 E Lincoln Ave, Rahway, NJ 07065, USA., Shedden K; Department of Statistics, University of Michigan, Ann Arbor, MI 48109, USA., Amidon GL; Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, 428 Church Street, Ann Arbor, MI 48109-1065, USA.
Publikováno v:
Pharmaceutics [Pharmaceutics] 2020 Jan 17; Vol. 12 (1). Date of Electronic Publication: 2020 Jan 17.
Autor:
Stepanova, Mariia1 (AUTHOR) maristepanova@hq.macro.ru, Levit, Mariia1 (AUTHOR) musia_1@yahoo.com, Egorova, Tatiana2 (AUTHOR) egorova25tat@yandex.ru, Nashchekina, Yulia3 (AUTHOR) ulychka@mail.ru, Sall, Tatiana4 (AUTHOR) miss_taty@mail.ru, Demyanova, Elena2 (AUTHOR) lenna_22@mail.ru, Guryanov, Ivan5 (AUTHOR) ivan.guryanov1@gmail.com, Korzhikova-Vlakh, Evgenia1 (AUTHOR) ivan.guryanov1@gmail.com
Publikováno v:
Pharmaceutics. Aug2024, Vol. 16 Issue 8, p1080. 22p.
Publikováno v:
Nigde Omer Halisdemir University Journal of Engineering Sciences / Niğde Ömer Halisdemir Üniversitesi Mühendislik Bilimleri Dergisi. 2024, Vol. 13 Issue 3, p1056-1073. 18p.
Autor:
Ekdahl A; Dosage Forms and Delivery Systems, Lonza Pharma and Biotech, Bend, Oregon 97703., Mudie D; Dosage Forms and Delivery Systems, Lonza Pharma and Biotech, Bend, Oregon 97703. Electronic address: deanna.mudie@lonza.com., Malewski D; Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, Michigan 48109; Social, Behavioral & Administrative Sciences, College of Pharmacy, Touro University California, Vallejo, California 94592., Amidon G; Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, Michigan 48109., Goodwin A; Dosage Forms and Delivery Systems, Lonza Pharma and Biotech, Bend, Oregon 97703; Formulation Development, Pfizer Inc., Boulder, Colorado 80301.
Publikováno v:
Journal of pharmaceutical sciences [J Pharm Sci] 2019 Nov; Vol. 108 (11), pp. 3657-3666. Date of Electronic Publication: 2019 Aug 22.
Autor:
Bermejo M; Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, MI 48109, USA. mbermejo@goumh.umh.es.; Department Engineering Pharmacy Section, Miguel Hernandez University, San Juan de Alicante, 03550 Alicante, Spain. mbermejo@goumh.umh.es., Kuminek G; Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, MI 48109, USA. gkuminek@umich.edu., Al-Gousous J; Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, MI 48109, USA. jalgouso@umich.edu.; Department of Biopharmaceutics and Pharmaceutical Technology, Johannes Gutenberg Universität Mainz, D-55099 Mainz, Germany. jalgouso@umich.edu., Ruiz-Picazo A; Department Engineering Pharmacy Section, Miguel Hernandez University, San Juan de Alicante, 03550 Alicante, Spain. alejandroruizpicazo@gmail.com., Tsume Y; Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, MI 48109, USA. ytsume@umich.edu.; Merck and Co., Inc., 126 E Lincoln Ave, Rahway, NJ 07065, USA. ytsume@umich.edu., Garcia-Arieta A; Service on Pharmacokinetics and Generic Medicines, Division of Pharmacology and Clinical Evaluation, Department of Human Use Medicines, Spanish Agency for Medicines and Health Care Products, 28022 Madrid, Spain. agarciaa@aemps.es., González-Alvarez I; Department Engineering Pharmacy Section, Miguel Hernandez University, San Juan de Alicante, 03550 Alicante, Spain. isabel.gonzalez@goumh.umh.es., Hens B; Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, MI 48109, USA. barthens@umich.edu.; Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Herestraat 49, 3000 Leuven, Belgium. barthens@umich.edu., Amidon GE; Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, MI 48109, USA. geamidon@umich.edu., Rodriguez-Hornedo N; Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, MI 48109, USA. nrh@umich.edu., Amidon GL; Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, MI 48109, USA. glamidon@umich.edu., Mudie D; Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, MI 48109, USA. deanna.mudie@lonza.com.; Drug Product Development and Innovation, Lonza Pharma and Biotech, Bend, OR 97703, USA. deanna.mudie@lonza.com.
Publikováno v:
Pharmaceutics [Pharmaceutics] 2019 Mar 15; Vol. 11 (3). Date of Electronic Publication: 2019 Mar 15.